Advertisement

Topics

Latest Gastroenterology NewsRSS

18:27 EST 19th January 2017 | BioPortfolio

Helsinn Healthcare SA Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryHelsinn Healthcare SA Helsinn Healthcare, a subsidiary of Helsinn Holding SA, which provides cancer care solutions. It offers products in various therapeutic areas that include pain and inflammation, cancer care and gastroenterology. Helsinn Healthcare's product portfolio include Aloxi, Gelclair, Akynzeo in the area of cancer; Nimesulide, in the area of pain and inflammation and KleanPrep a...

PurpleStride Miami Aims to Double Pancreatic Cancer Survival by 2020

Community unites to raise funds, advance research, support patients affected by nation’s deadliest major cancer For the third consecutive year, the five-year survival rate for pancreatic cancer increased and is now nine percent

Voice Analysis Tech Could Diagnose Disease

Researchers enlist smartphones and machine learning to find vocal patterns that might signal post-traumatic stress disorder or even heart disease.

BioNJ’s Gateway Gala to Salute Patients and the Innovator Companies Inspired by Them

Featuring a Keynote by Breast Cancer Survivor, Advocate & Former Good Morning America Host Joan Lunden, the Presentation of the Dr. Sol J. Barer Award and the Innovation Awards Ceremony BioNJ will present Innovator Awards honoring industry leaders, policy champions and Patient advocates who have reached significant milestones, as well as compa...

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath

VOC – Biomarkers for Disease Diagnosis: Sniffing Out Cancer: Israeli Prof. Finds Diseases Like Cancer And Parkinson’s Can Be Detected On The Breath Reporter: Aviva Lev-Ari, PhD, RN   VOC – Volatile Organic Compounds as BioMarkers. Image Source: http://nocamels.com/2017/01/disease-detection-smelling-breath/?utm_source=activetrail&utm_medium=email&utm_campaign=nc19/1/17 V...

Lisa Lange, ANP-BC, AOCN, of Karmanos Cancer Institute promoted to vice president of the Clinical Trials Office

DETROIT, Jan. 19, 2017 /PRNewswire-USNewswire/ -- Lisa Lange, ANP-BC, AOCN, of the Barbara Ann Karmanos Cancer Institute, has been promoted to vice president of the Clinical Trials Office (CTO), effective immediately. Lange brings 26 years of experience as a nurse and nurse practitioner, specialized in clinical oncology care and research. She has been with Karmanos for 19 years, increasing her man...

MPI's spinout Oncology Venture granted EUROSTARS funding for PoC of LiPlaCis

Hoersholm, Denmark, January 19th, 2017 - Medical Prognosis Institute A/S (MPI.ST) (Denmark and Phoenix, AZ, USA) today announced that Oncology Venture Sweden AB (OV.ST) a spinout from MPI and OV's strategic partner Smerud Medical Research International AS (SMERUD), have been granted EUROSTARS funds from the  Norwegian Research Council and Innovationsfonden in Denmark for the ...

GONITRO™ to Participate in First-of-its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial Sponsored by the National Institutes of Health

Espero Pharmaceuticals donates GoNitro™ to clinical trial in collaboration with more than 120 U.S. medical centers to evaluate treatment options for patients with stable ischemic heart disease Espero Pharmaceuticals, Inc., a commercial-stage cardiovascular pharmaceutical company, will donate GONITRO™ (nitroglycerin sublingual powder) to the ongoing...

OncLive® Seeks Nominations for 5th Annual Giants of Cancer Care® Awards

A Distinguished Award to honor those who have made major contributions in the lives of patients with cancer. Cranbury, NJ (PRWEB) January 19, 2017 OncLive® is seeking nominations for its 2017 Giants of Cancer Care® Awards, which recognizes the top oncologists and researchers who have made remarkable achievements in oncology research and clinical practice, announced OncLive® Preside...

A First Look at Reproducibility in Cancer Biology

I’ve been waiting for these results: the Reproducibility Project (Cancer Biology) has been going back over several prominent papers in the field, seeing how well their results hold up. This follows a similar effort in experimental psychology, where the results were mixed. The hopes here were to reproduce 50 high-profile studies, but as this Nature

Osteoporosis and Inflammatory Bowel Disease

Osteoporosis, or “thinning of the bones,” is a concern among many women, especially those who are experiencing or have experienced menopause. Osteoporosis increases one’s susceptibility to developing fractures of the bones in the wrist, ribs, vertebral spine and hips, often with minimal trauma. Osteoporosis accounts for 1.5 million fractures and results in more than $13 billion in medical co...

Comorbidities in Rheumatoid Arthritis: More Work or Part of Job?

Caring for patients with rheumatoid arthritis today is a joy compared to the challenge posed merely a generation ago. However, this transformation has come with costs in terms of our efforts. When we had little to offer in terms of treating the underlying disease, the primary challenges were to stop progressive bone destruction and attendant incapacity, as well as focus on the ravages of complicat...

Controversy surrounds stem cell treatments for cancer, other disorders

[Stem cell research] is now considered among the most seminal medical findings of the past century, on a par with the discovery of the double-helical structure of

Stem cells lay foundation for treatments of cancer, other disorders

[Stem cell research] is now considered among the most seminal medical findings of the past century, on a par with the discovery of the double-helical structure of

PET/MRI in Primary Staging of Laryngeal Cancer

Examination with PET/ MRI for patients with laryngeal cancer.

OARSI white paper on burden of OA submitted to FDA drives home seriousness of disease

Leadership of Osteoarthritis Research Society International recently submitted a white paper entitled, “Osteoarthritis: A serious disease,” to the FDA to garner greater attention of the FDA, policy makers and other regulatory agencies to the work that remains to be done to identify effective therapies for osteoarthritis.The main argument of the Osteoarthritis Research Society International (OA...

Ambry Genetics’ Big Data Sharing Program Now Available for Public Download

Ambry Genetics’ (Ambry) data sharing program, AmbryShare, is one of the largest germline exome data sets on hereditary breast and ovarian cancer available, with more than 1 million variants from 11,400 patients. This repository, originally announced in March of 2016 and previously only available to select researchers, is now publicly available for downlo...

Registered Dietitian And Diabetes Expert Angela Ginn-Meadow Joins The Grain Foods Foundation Scientific Advisory Board

WASHINGTON, Jan. 19, 2017 /PRNewswire/ -- Today, the Grain Foods Foundation announced the addition of Registered Dietitian and Certified Diabetes Educator Angela Ginn-Meadow to its Scientific Advisory Board. Ginn-Meadow brings to the position her expertise in diabetes and endocrine disorders along with her experience helping people make healthier choices in their everyday lives. In this ...

Cytori to Acquire Azaya Platform, Cancer Candidates

Cytori Therapeutics said today it plans to acquire the liposomal nanoparticle technology platform of Azaya Therapeutics for up to $170 million, in a deal designed to expand and complement the buyer’s regenerative medicine operations. Azaya’s Protein Stabilized Liposomes™ (PSL) platform is designed to allow for high-dose delivery of potent cytotoxics with potentially lower side effects.&#...

Liquid Biopsy Market is Predicted to Grow at a CAGR of 21.6% from 2016 to 2022

PUNE, India, Jan. 19, 2017 /PRNewswire/ -- Market Research Future has a half cooked research report on Global Liquid Biopsy Market. The Global Market for Liquid Biopsy is growing rapidly and expected to reach USD 450 Million by the end of the forecasted period. Market Highlights The Global Liquid Biopsy Market has been assessed as a swiftly growing market and expected that the market...

Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells

SAN DIEGO, Jan. 19, 2017 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of clinically actionable liquid biopsy tests to improve the management of cancer patients, announces that it has been awarded Australian Patent No. 2010229924 entitled, DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS. The issued patent covers the use of antibodies in microchannels for the cap...

Attorney Robert “RC” Pate Helping Improve the Lives of Children with Cancer

Robert “RC” Pate, of The Law Office of RC Pate, supports Triumph Over Kid Cancer foundation with donation. San Antonio, TX (PRWEB) January 19, 2017 Attorney Robert “RC” Pate, founder of The Law Office of RC Pate, has for the fifth consecutive year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. In 2006, 13-year-old...

Suspected Yellow Fever Outbreak in Brazil

According to the World Health Organization, relatively low vaccination coverage in the state of Minas Gerais “could favor the rapid spread of the disease.”

Lungevity Foundation Partners With CancerCare To Launch Lung Cancer Helpline

WASHINGTON, Jan. 19, 2017 /PRNewswire/ -- LUNGevity, the nation's leading lung cancer-focused nonprofit organization, today announced the launch of the LUNGevity Lung Cancer HELPLine, a free phone service through which a team of professional oncology social workers will be available to address the emotional, practical, and information needs of people diagnosed with lung cancer, their families...

New Review of Optimising Clinical Outcomes in Gastrointestinal Cancers Through Inhibiting Angiogenesis and Other Signalling Pathways

LONDON, January 19, 2017 /PRNewswire/ -- James Gilbart, Axel Grothey; European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO ) Published recently in a supplement to Euro...

Quick Search
Advertisement
 

review and buy Gastroenterology market research data and corporate reports here